Learn More
Description
Reacts with a 25-35kDa molecule expressed on 1-4% of human fetal liver cells, cord blood cells, and bone marrow cells. Anti-CD90 reacts with a subset of immature, CD34+ celsl and a distinct subset of mature CD34- cells that are CD3+ CD4+ . The CD90+ CD34+ population is highly enriched for cells capable of long-term culture. Anti-CD90 is useful for enriching high proliferative potential colony-forming cells (HIPP-CFC) which are primative progenitor cells. This antibody is routinely tested by flow cytometric analysis. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
Specifications
Specifications
| Antigen | CD90 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | 5.00E+10 |
| Concentration | 0.5mg/mL |
| Conjugate | Unconjugated |
| Description | THY1; Thy-1 antigen; Thy-1 membrane glycoprotein |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Human HEL Cell Line |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.